Ingevity Chief Financial Officer Phillip Platt Sells 3,294 Shares in Open-Market Transaction

Senior Executive Share Disposition Details

The disclosure document reveals that Phillip John Platt, who serves as Senior Vice President and Chief Financial Officer at Ingevity Corp, engaged in a securities transaction involving the sale of 3,294 shares of common stock. The transaction was executed on July 24, 2026, at a transaction price of $73.26 per share. According to the filing, the shares were sold as a result of withholding by the company to satisfy tax obligations associated with restricted stock units that vested on the same date. This type of equity activity is common among senior executives when restricted awards reach their vesting date.

The nature of this transaction—specifically the withholding of shares to cover tax liabilities—is a standard practice in equity compensation arrangements. When restricted stock units vest, companies typically retain a portion of the awarded shares to cover federal, state, and local tax withholding requirements on behalf of the executive. The filing explicitly states that the 3,294 shares were withheld by Ingevity to satisfy tax withholding obligations related to the restricted stock units that vested on July 24, 2026. This mechanism allows executives to receive the net benefit of their equity awards without requiring out-of-pocket tax payments at vesting.

CFO's Remaining Shareholding Position

Following the transaction, Phillip Platt maintained direct beneficial ownership of 28,339 shares of Ingevity common stock. This direct holding represents his personal stake in the company, separate from any other equity interests or derivative securities he may hold. The disclosure indicates that all of these shares are held directly, rather than through any indirect ownership structure or entity. Tracking executive shareholdings is important for investors monitoring management's financial alignment with the company and gauging confidence in Ingevity's future performance.

The size of Platt's remaining shareholding demonstrates a continued material personal investment in Ingevity. With 28,339 shares at the reported transaction price of $73.26, this represents a direct equity stake valued at approximately $2.08 million at the time of the vesting event. This level of ownership among senior financial leadership can signal management's confidence in the company's strategic direction and operational prospects. Investors often view significant insider shareholdings as an indicator that executives have skin in the game and are incentivized to execute effectively on corporate strategy.

Tax Withholding Mechanics in Equity Compensation

Restricted stock unit vesting events trigger tax withholding obligations for executives, and companies typically handle these requirements through share withholding arrangements rather than requiring cash payments from the recipient. In Platt's case, the filing confirms that 3,294 shares were withheld to satisfy the tax liabilities arising from the July 24, 2026 vesting event. This approach is administratively efficient and provides executives with net equity benefits without creating liquidity pressures. The transaction code used in the filing—code F, which denotes shares withheld to cover tax obligations—reflects this routine withholding mechanism.

From a regulatory perspective, share withholding transactions are distinct from open-market sales or planned trading activities. The Securities and Exchange Commission recognizes that withholding for tax purposes is a necessary component of equity award administration and not indicative of an executive's personal investment thesis regarding the company's stock. The filing clearly delineates this transaction as one driven by tax compliance rather than a discretionary investment decision by Platt. This distinction is important for investors interpreting insider transaction data, as it separates involuntary equity reductions driven by tax obligations from voluntary share sales that might reflect an executive's market outlook.

Ingevity Corp's Executive Compensation Structure

Ingevity's use of restricted stock units as a component of executive compensation reflects a broader practice within publicly traded companies to align management incentives with shareholder interests. Restricted stock awards typically vest over a period of years, encouraging executives to remain with the organization and perform effectively over a multi-year horizon. The vesting of Platt's restricted stock units on July 24, 2026, represents the completion of a vesting schedule for one tranche of his equity compensation award. As Chief Financial Officer, Platt's compensation package likely includes a combination of base salary, performance-based cash incentives, and equity awards such as restricted stock units and stock options.

The use of tax withholding provisions in equity compensation design protects executives from the tax consequences of equity awards while preserving their net benefit. This approach has become standard across publicly traded companies, including those in specialty chemicals and materials sectors like Ingevity. By withholding shares at vesting rather than requiring executives to liquidate shares or provide cash for taxes, companies facilitate better employee retention and reduce administrative friction in equity compensation programs. Ingevity's implementation of this practice with Platt's award vesting is consistent with market-standard equity administration practices.

Timing and Regulatory Reporting of Insider Transactions

The filing was submitted on July 28, 2026, four days after the underlying transaction occurred on July 24, 2026. This timing aligns with Securities and Exchange Commission requirements for timely disclosure of insider transactions by officers and directors of public companies. Section 16 of the Securities Exchange Act of 1934 imposes reporting obligations on officers, directors, and beneficial owners of more than 10 percent of a company's securities. As Senior Vice President and Chief Financial Officer, Platt falls within the officer category and is required to report all transactions in Ingevity securities within the prescribed timeframe. The prompt filing of this transaction demonstrates compliance with these regulatory obligations.

Ingevity investors and market participants rely on these timely disclosures to maintain transparency regarding insider trading activity and executive shareholdings. The Form 4 filing provides detailed information about the transaction date, price, quantity, and nature of the transaction, enabling public market participants to assess executive activity. The four-day reporting window between transaction execution and filing submission is typical for insider transaction disclosures and reflects the company's internal compliance processes and SEC's filing systems. Investors monitoring Ingevity's insider activity can use these disclosures as part of a broader analysis of management activity and market sentiment.

CFO Role and Financial Leadership at Ingevity

Phillip Platt's position as Senior Vice President and Chief Financial Officer places him among Ingevity's senior executive leadership team. As CFO, Platt is responsible for financial planning, accounting, treasury operations, investor relations, and other critical financial management functions. Senior financial executives typically have significant exposure to equity compensation through their compensation packages, as equity awards serve to align their interests with shareholder value creation. The vesting of Platt's restricted stock units reflects his ongoing participation in Ingevity's equity compensation program as a key member of the executive team.

The CFO role is particularly important in specialty chemicals and materials companies like Ingevity, where capital allocation decisions, working capital management, and financial strategy significantly impact shareholder returns. By holding a material personal stake in the company, Platt's interests are aligned with those of other shareholders seeking long-term value creation. His continued beneficial ownership of 28,339 shares following the tax withholding transaction demonstrates a maintained financial commitment to Ingevity. Investors often view CFO shareholdings as relevant data points when assessing management quality and strategic confidence, particularly in capital-intensive industrial sectors.

Market Context and Share Price at Transaction Date

The transaction price of $73.26 per share reported in the filing reflects the price at which shares were deemed to be withheld for tax purposes in connection with the restricted stock unit vesting on July 24, 2026. This price represents the fair market value of Ingevity common stock at the vesting date and serves as the basis for calculating the number of shares withheld to satisfy Platt's tax obligations. The filing does not provide information regarding Ingevity's broader market performance, trading volume, or analyst sentiment during this period. The immediate share price impact was not clear from available public information.

The $73.26 transaction price is a factual data point recorded in the regulatory filing and reflects the valuation of Ingevity's equity at the specific time the vesting event occurred. Investors interested in understanding Ingevity's trading activity and price movements during late July 2026 would need to consult historical price data, trading volumes, and market analysis from financial data providers. The filing itself focuses narrowly on the details of Platt's transaction and beneficial ownership position, rather than providing broader market context or forward-looking statements about Ingevity's stock performance.

Beneficial Ownership and Shareholder Transparency

Beneficial ownership disclosures serve as a critical transparency mechanism in securities regulation, enabling investors to understand the extent to which company insiders have financial stakes in the business. The filing identifies Platt's direct beneficial ownership of 28,339 shares following the transaction, representing his unencumbered, personal shareholding in Ingevity. Direct beneficial ownership differs from indirect ownership through trusts, partnerships, or other entities, and the filing specifies that Platt's shares are held directly. This clear delineation helps investors understand the nature and extent of Platt's financial interest in the company.

Transparency regarding insider shareholdings supports market efficiency and reduces information asymmetries between company insiders and public investors. When investors can readily access data on executive and director shareholdings through regulatory filings, they gain insight into management's commitment to the company and potential alignment of interests. Platt's maintenance of approximately 28,000 shares of Ingevity stock represents a tangible personal investment that investors can consider when evaluating management quality and strategic confidence. The disclosure of these shareholdings through Form 4 filings ensures that all market participants have equal access to this information.